EARLY ANTIBODY THERAPY CAN INDUCE LONG LASTING IMMUNITY TO SHIV

Highly potent and broadly neutralizing anti-HIV-1 antibodies (bNAbs) have been used to prevent and treat lentivirus infections in humanized mice, macaques and humans(1–12). To determine whether the administration of combination bNAbs during the acute SHIV infection of rhesus macaques might lead to l...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nature
Auteurs principaux: Nishimura, Yoshiaki, Gautam, Rajeev, Chun, Tae-Wook, Sadjadpour, Reza, Foulds, Kathryn E., Shingai, Masashi, Klein, Florian, Gazumyan, Anna, Golijanin, Jovana, Donaldson, Mitzi, Donau, Olivia K., Plishka, Ronald J., Buckler-White, Alicia, Seaman, Michael S., Lifson, Jeffrey D., Koup, Richard A., Fauci, Anthony S., Nussenzweig, Michel C., Martin, Malcolm A.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458531/
https://ncbi.nlm.nih.gov/pubmed/28289286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nature21435
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires